![](https://www.ingredients-insight.com/wp-content/uploads/sites/10/2025/02/vitamin-5033571_1920-428x241.webp)
AgelessRx, a pioneer in longevity and telehealth solutions, announced the introduction of oral sublingual drops for GLP-1 receptor agonists Semaglutide and Tirzepatide. By offering non-injectable alternatives to medications that may support metabolic health management and counter the effects of aging, AgelessRx continues to empower individuals to live longer, healthier lives.
Optimal metabolic health is a foundational component of longevity. Dysregulated glucose levels, visceral fat accumulation, and other markers of poor metabolic function accelerate biological aging and increase the risk of chronic diseases, such as cardiovascular disease, Type 2 diabetes, and liver disease, making GLP-1s critical for overall health and healthspan.
“Our mission is to make longevity accessible for all, and GLP-1s are a core piece of that puzzle,” said Stefanie Morgan, Vice President of Applied Sciences at AgelessRx. “The impact of these medications is proving to go beyond traditional uses to significantly improve key health metrics – from metabolic health, to glucose regulation, liver function, heart health, and even sleep – that could be foundational to a long, healthy life and a key driver in longevity.”
Recent research shows that about one in eight adults have taken a GLP-1 in their lifetime. Unlike conventional approaches, these medications may do more than manage symptoms – they may work at a biological level to support overall health. These benefits directly contribute to increased healthspan by potentially delaying the onset of chronic diseases and supporting cellular resilience. Compounded with a SubMagna SL HMW, AgelessRx’s sublingual methods bypass digestion for quicker, more efficient delivery into the bloodstream as compared to other oral methods such as digestible tablets.
As a longevity-focused telehealth platform, AgelessRx’s Stanford PhD-led Applied Sciences team is actively exploring the broader applications of GLP-1s in promoting lifespan and longevity. The introduction of oral GLP-1s reflects the company’s dedication to the core principles of longevity – prevention of chronic conditions through better metabolic control, personalization of care to meet individual health needs, and proactivity in empowering individuals to take charge of their long-term well-being. By making these transformative therapies more accessible and adaptable to individual needs, AgelessRx is helping to bring longevity-focused care within reach for millions.